Carfilnat 60mg Injection is used to treat
- Treatment of multiple myeloma
MRP | : |
|
Price | : | ₹7,600.00 |
You Save | : | ₹1,765.63 (18.85%) |
1 Vial(s)
Carfilnat 60mg Injection is an anticancer drug that contains the active ingredient Carfilzomib. It is utilized for the treatment of a specific type of cancer known as multiple myeloma. Multiple myeloma is characterized by the uncontrolled growth of plasma cells, a type of white blood cell, which accumulate in the bone marrow, leading to damage to the bones and kidneys.
This medication helps alleviate symptoms associated with multiple myeloma, including bone pain, fatigue, and anemia, thereby enhancing the quality of life for patients.
When used alongside other treatments, this medication can significantly improve survival rates for those with multiple myeloma. It is frequently administered in conjunction with other drugs. As with all medications, there are potential side effects. Commonly reported side effects include fatigue, nausea, vomiting, diarrhea, fever, and decreased blood cell counts. It is crucial for patients to maintain proper hydration while receiving Carfilnat 60mg Injection, as it can lead to dehydration, which may worsen some side effects. Overall, it is an effective treatment for multiple myeloma, and for many patients, the advantages may outweigh the potential risks.
Carfilnat 60mg Injection is used to treat
Carfilnat 60mg Injection is classified as a proteasome inhibitor, meaning it functions by inhibiting the activity of proteasomes, the enzymes that break down proteins within cells. By obstructing proteasomes, this drug can hinder the growth and survival of cancer cells, ultimately resulting in their death. This mechanism can aid in slowing or halting the advancement of multiple myeloma and may enhance survival rates for certain patients.
Notify your healthcare provider of all medications you are taking, including prescription drugs, over-the-counter medications, nutritional or vitamin supplements, and herbal products.
Some medications may interact with Carfilnat 60mg Injection, potentially diminishing its effectiveness and leading to unwanted side effects.
Carfilnat 60mg Injection is generally given as an intravenous (IV) injection in a hospital or clinical environment by a healthcare professional. The precise dosage and frequency of administration will vary based on the specific condition being treated and other individual factors, including the patient's age, weight, and overall health.
If a dose is missed, reach out to your healthcare provider to discuss the best course of action. If the missed dose is identified within a few hours of the scheduled time, your healthcare provider may suggest administering the missed dose as soon as possible while keeping the usual interval between doses. However, if more than a few hours have elapsed since the missed dose, your healthcare provider may advise skipping the missed dose and continuing with the regular dosing schedule at the next scheduled time. It is crucial not to take two doses to compensate for a missed one.
Serious:
Common side:
It is crucial to administer the Carfilnat 60mg Injection according to the instructions provided by a healthcare professional.
Patients must also notify their doctor about any existing medical conditions and any other medications they are currently using.
Being aware of the possible side effects of Carfilnat 60mg Injection is essential, and any concerns should be communicated to your healthcare provider.
Women who are pregnant or breastfeeding should seek advice from their doctor prior to using this medication, as it may pose risks to the baby.
There are no specific dietary limitations for individuals taking this medication.
Nonetheless, it is generally advisable for cancer patients to adhere to a healthy and balanced diet to enhance their overall health and well-being.
Staying well-hydrated by drinking plenty of water and other fluids, such as clear broths or herbal teas, can assist in preventing dehydration.
Molecule Name: Carfilzomib
Therapeutic Class: Anticancer
Pharmacological Class: Protease Inhibitor
Indications:
Multiple myeloma
At Medfast, we’re dedicated to bringing you accurate, trustworthy, and expert-vetted health information. Our primary goal is to ensure you receive content that you can rely on.
It’s crucial to understand that everything on this website is for general information purposes only. This content is not a substitute for professional medical advice, diagnosis, or treatment. We can’t stress enough the importance of consulting with your own doctor. They are the only ones who can provide tailored advice for your specific health concerns or medication questions.
Please, never ignore or delay seeking professional medical advice because of something you’ve read here. Our fundamental mission is to support and enhance the doctor-patient relationship, not to replace it.
We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.
100% secure and trusted payment protection
We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.